Kirsten E. Bailey

920 total citations
30 papers, 620 citations indexed

About

Kirsten E. Bailey is a scholar working on Clinical Biochemistry, Applied Microbiology and Biotechnology and Infectious Diseases. According to data from OpenAlex, Kirsten E. Bailey has authored 30 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Clinical Biochemistry, 9 papers in Applied Microbiology and Biotechnology and 8 papers in Infectious Diseases. Recurrent topics in Kirsten E. Bailey's work include Bacterial Identification and Susceptibility Testing (16 papers), Antibiotic Use and Resistance (9 papers) and Veterinary Practice and Education Studies (6 papers). Kirsten E. Bailey is often cited by papers focused on Bacterial Identification and Susceptibility Testing (16 papers), Antibiotic Use and Resistance (9 papers) and Veterinary Practice and Education Studies (6 papers). Kirsten E. Bailey collaborates with scholars based in Australia, United States and Canada. Kirsten E. Bailey's co-authors include James R. Gilkerson, Glenn F. Browning, Laura Y. Hardefeldt, Helen Billman‐Jacobe, Mark A. Stevenson, Karin Thursky, Michael D. Shields, Carol A. Hartley, Philip D. Sloane and John Dallara and has published in prestigious journals such as Journal of Accounting Research, Veterinary Microbiology and Veterinary Record.

In The Last Decade

Kirsten E. Bailey

28 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kirsten E. Bailey Australia 15 165 160 132 90 76 30 620
Antonio Sorlózano Spain 17 63 0.4× 103 0.6× 142 1.1× 22 0.2× 20 0.3× 61 1.0k
Caroline King United Kingdom 10 124 0.8× 71 0.4× 36 0.3× 33 0.4× 5 0.1× 18 396
Ka Lip Chew Singapore 17 67 0.4× 113 0.7× 295 2.2× 45 0.5× 2 0.0× 53 821
James Stewart Australia 14 17 0.1× 26 0.2× 69 0.5× 11 0.1× 32 0.4× 30 518
Gwen Rees United Kingdom 13 32 0.2× 32 0.2× 28 0.2× 64 0.7× 5 0.1× 34 504
Farhad B. Hashemi Iran 22 73 0.4× 62 0.4× 249 1.9× 9 0.1× 13 0.2× 46 1.2k
Mariana Catalano Argentina 21 67 0.4× 46 0.3× 250 1.9× 153 1.7× 3 0.0× 46 1.2k
Heather Fowler United States 9 27 0.2× 29 0.2× 32 0.2× 58 0.6× 2 0.0× 17 374
Katsuaki Sugiura Japan 17 16 0.1× 4 0.0× 98 0.7× 100 1.1× 56 0.7× 107 968
Florian Szabados Germany 18 35 0.2× 328 2.0× 259 2.0× 4 0.0× 4 0.1× 29 945

Countries citing papers authored by Kirsten E. Bailey

Since Specialization
Citations

This map shows the geographic impact of Kirsten E. Bailey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsten E. Bailey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsten E. Bailey more than expected).

Fields of papers citing papers by Kirsten E. Bailey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirsten E. Bailey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsten E. Bailey. The network helps show where Kirsten E. Bailey may publish in the future.

Co-authorship network of co-authors of Kirsten E. Bailey

This figure shows the co-authorship network connecting the top 25 collaborators of Kirsten E. Bailey. A scholar is included among the top collaborators of Kirsten E. Bailey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirsten E. Bailey. Kirsten E. Bailey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilkerson, James R., et al.. (2025). Outcomes from an intervention study implementing fee‐free culture and susceptibility urine testing in dogs and cats. Veterinary Record. 198(5). e201–e208.
2.
Bailey, Kirsten E., et al.. (2024). Seeking simplicity, navigating complexity: How veterinarians select an antimicrobial drug, dose, and duration for companion animals. Journal of Veterinary Internal Medicine. 38(6). 3215–3234. 3 indexed citations
3.
Browning, Glenn F., et al.. (2023). ‘Brave Enough’: A Qualitative Study of Veterinary Decisions to Withhold or Delay Antimicrobial Treatment in Pets. Antibiotics. 12(3). 540–540. 11 indexed citations
4.
Bailey, Kirsten E., et al.. (2023). Cross‐sectional evaluation of a large‐scale antimicrobial stewardship trial in Australian companion animal practices. Veterinary Record. 194(4). e3268–e3268. 3 indexed citations
5.
Hardefeldt, Laura Y., Glenn F. Browning, J. Scott Weese, & Kirsten E. Bailey. (2023). A Global Evaluation of Generic Antimicrobial Prescribing Competencies for Use in Veterinary Curricula. Journal of Veterinary Medical Education. 51(5). 695–700.
6.
Hardefeldt, Laura Y., et al.. (2022). Antimicrobial stewardship in companion animal practice: an implementation trial in 135 general practice veterinary clinics. JAC-Antimicrobial Resistance. 4(1). dlac015–dlac015. 15 indexed citations
7.
Hardefeldt, Laura Y., et al.. (2021). Pet Owners and Antibiotics: Knowledge, Opinions, Expectations, and Communication Preferences. Antibiotics. 10(11). 1326–1326. 20 indexed citations
8.
Hardefeldt, Laura Y., Kirsten E. Bailey, & Josh Slater. (2020). Overview of the use of antimicrobial drugs for the treatment of bacterial infections in horses. Equine Veterinary Education. 33(11). 602–611. 13 indexed citations
9.
Hardefeldt, Laura Y., Karin Verspoor, Timothy Baldwin, et al.. (2020). Use of cefovecin in dogs and cats attending first‐opinion veterinary practices in Australia. Veterinary Record. 187(11). e95–e95. 19 indexed citations
11.
Hardefeldt, Laura Y., et al.. (2019). Survey of veterinary prescribing for poultry disease. Australian Veterinary Journal. 97(8). 288–288. 3 indexed citations
12.
Hardefeldt, Laura Y., Mark A. Stevenson, James R. Gilkerson, et al.. (2018). Population wide assessment of antimicrobial use in dogs and cats using a novel data source – A cohort study using pet insurance data. Veterinary Microbiology. 225. 34–39. 45 indexed citations
13.
Hardefeldt, Laura Y., James R. Gilkerson, Helen Billman‐Jacobe, et al.. (2018). Barriers to and enablers of implementing antimicrobial stewardship programs in veterinary practices. Journal of Veterinary Internal Medicine. 32(3). 1092–1099. 97 indexed citations
14.
Hardefeldt, Laura Y., Glenn F. Browning, Karin Thursky, et al.. (2017). Antimicrobials used for surgical prophylaxis by companion animal veterinarians in Australia. Veterinary Microbiology. 203. 301–307. 24 indexed citations
15.
Gilkerson, James R., et al.. (2015). Update on Viral Diseases of the Equine Respiratory Tract. Veterinary Clinics of North America Equine Practice. 31(1). 91–104. 38 indexed citations
16.
Bailey, Kirsten E., James R. Gilkerson, & Glenn F. Browning. (2013). Equine rotaviruses—Current understanding and continuing challenges. Veterinary Microbiology. 167(1-2). 135–144. 33 indexed citations
17.
Bailey, Kirsten E.. (2000). Student awareness of Alzheimer's disease. American Journal of Alzheimer s Disease & Other Dementias®. 15(6). 375–378. 5 indexed citations
18.
Bailey, Kirsten E., et al.. (1995). Smoking in hotels: prevalence, and opinions about restrictions. Australian Journal of Public Health. 19(1). 98–100. 7 indexed citations
19.
Sloane, Philip D., et al.. (1994). Management of dizziness in primary care.. PubMed. 7(1). 1–8. 55 indexed citations
20.
Bailey, Kirsten E.. (1993). Which primary care patients with dizziness will develop persistent impairment?. Archives of Family Medicine. 2(8). 847–852. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026